These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 19144261

  • 1. Comparative study of sensory attributes of two antihistamine nasal sprays: olopatadine 0.6% and azelastine 0.1%.
    Meltzer EO, Garadi R, Laforce C, Chadwick SJ, Berger WE, Gross G, Edwards MR, Crenshaw K, Wall GM.
    Allergy Asthma Proc; 2008; 29(6):659-68. PubMed ID: 19144261
    [Abstract] [Full Text] [Related]

  • 2. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
    Shah SR, Nayak A, Ratner P, Roland P, Michael Wall G.
    Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710
    [Abstract] [Full Text] [Related]

  • 3. Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis.
    Lieberman P, Meltzer EO, LaForce CF, Darter AL, Tort MJ.
    Allergy Asthma Proc; 2011 Jan; 32(2):151-8. PubMed ID: 21352639
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis.
    LaForce CF, Carr W, Tilles SA, Chipps BE, Storms W, Meltzer EO, Edwards M.
    Allergy Asthma Proc; 2010 Jan; 31(2):132-40. PubMed ID: 20302683
    [Abstract] [Full Text] [Related]

  • 5. Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study.
    Meltzer EO, Stahlman JE, Leflein J, Meltzer S, Lim J, Dalal AA, Prillaman BA, Philpot EE.
    Clin Ther; 2008 Feb; 30(2):271-9. PubMed ID: 18343265
    [Abstract] [Full Text] [Related]

  • 6. Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: olopatadine hydrochloride versus mometasone furoate monohydrate.
    Patel D, Garadi R, Brubaker M, Conroy JP, Kaji Y, Crenshaw K, Whitling A, Wall GM.
    Allergy Asthma Proc; 2007 Feb; 28(5):592-9. PubMed ID: 18034980
    [Abstract] [Full Text] [Related]

  • 7. Patient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride/Mometasone Furoate Monohydrate and Azelastine Hydrochloride/Fluticasone Propionate for Allergic Rhinitis in Australia - An Observational Real-World Clinical Study.
    Fifer S, Toh L, Barkate H, Aggarwal V, Borade D, Gordonsmith RH, Wu W, Morgan C, Young K.
    Patient Prefer Adherence; 2023 Feb; 17():141-151. PubMed ID: 36687019
    [Abstract] [Full Text] [Related]

  • 8. Comprehensive report of the efficacy, safety, quality of life, and work impact of Olopatadine 0.6% and Olopatadine 0.4% treatment in patients with seasonal allergic rhinitis.
    Fairchild CJ, Meltzer EO, Roland PS, Wells D, Drake M, Wall GM.
    Allergy Asthma Proc; 2007 Feb; 28(6):716-23. PubMed ID: 18201438
    [Abstract] [Full Text] [Related]

  • 9. Azelastine and olopatadine in the treatment of allergic rhinitis.
    Kaliner MA.
    Ann Allergy Asthma Immunol; 2009 Nov; 103(5):373-80. PubMed ID: 19927534
    [Abstract] [Full Text] [Related]

  • 10. Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis.
    Bachert C, El-Akkad T.
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):292-7. PubMed ID: 12269650
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of olopatadine hydrochloride nasal spray 0.6% in pediatric subjects with allergic rhinitis.
    Berger WE, Ratner PH, Casale TB, Meltzer EO, Wall GM.
    Allergy Asthma Proc; 2009 Sep; 30(6):612-23. PubMed ID: 20031007
    [Abstract] [Full Text] [Related]

  • 12. The effects of the nasal antihistamines olopatadine and azelastine in nasal allergen provocation.
    Pipkorn P, Costantini C, Reynolds C, Wall M, Drake M, Sanico A, Proud D, Togias A.
    Ann Allergy Asthma Immunol; 2008 Jul; 101(1):82-9. PubMed ID: 18681089
    [Abstract] [Full Text] [Related]

  • 13. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
    Carr WW, Ratner P, Munzel U, Murray R, Price D, Canonica GW, Mullol J, Virchow JC, Lieberman P, Meltzer E, Bachert C.
    Allergy Asthma Proc; 2012 Jul; 33(6):450-8. PubMed ID: 23127291
    [Abstract] [Full Text] [Related]

  • 14. Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCl nasal spray 0.6% compared with vehicle placebo.
    Hampel FC, Ratner PH, Amar NJ, van Bavel JH, Mohar D, Fairchild CJ, Wall GM, Brubaker MJ, Drake M, Crenshaw KM.
    Allergy Asthma Proc; 2006 Jul; 27(3):202-7. PubMed ID: 16913262
    [Abstract] [Full Text] [Related]

  • 15. Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitis.
    Kaliner MA, Storms W, Tilles S, Spector S, Tan R, LaForce C, Lanier BQ, Chipps B.
    Allergy Asthma Proc; 2009 Jul; 30(3):255-62. PubMed ID: 19549426
    [Abstract] [Full Text] [Related]

  • 16. Assessment of sensory perceptions and patient preference for intranasal corticosteroid sprays in allergic rhinitis.
    Khanna P, Shah A.
    Am J Rhinol; 2005 Jul; 19(3):316-21. PubMed ID: 16011141
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of intranasal olopatadine in the fixed-dose combination GSP301 versus two monotherapy intranasal olopatadine formulations.
    Patel P, Salapatek AM, Talluri RS, Tantry SK.
    Allergy Asthma Proc; 2018 May 01; 39(3):224-231. PubMed ID: 29669667
    [Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis.
    Meltzer EO, Hampel FC, Ratner PH, Bernstein DI, Larsen LV, Berger WE, Finn AF, Marple BF, Roland PS, Wall GM, Brubaker MJ, Dimas C, Potts SL, Silver LH, Barnes JR.
    Ann Allergy Asthma Immunol; 2005 Dec 01; 95(6):600-6. PubMed ID: 16400902
    [Abstract] [Full Text] [Related]

  • 19. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
    Ratner PH, Hampel F, Van Bavel J, Amar NJ, Daftary P, Wheeler W, Sacks H.
    Ann Allergy Asthma Immunol; 2008 Jan 01; 100(1):74-81. PubMed ID: 18254486
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis.
    Banov CH, Lieberman P, Vasomotor Rhinitis Study Groups.
    Ann Allergy Asthma Immunol; 2001 Jan 01; 86(1):28-35. PubMed ID: 11206234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.